30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: Symmetry Medical

$101.3MM, +2%

  • Instruments $28.9MM, +2%
  • Implants $28.4MM, +9%
  • Cases $15.7MM, -4%
  • Other $7.6MM, +25%
  • Surgical $20.7MM, -7%


  • Noted signs of increased business related to supplier rationalization efforts by one OEM customer
  • Expecting to see stability in OEM investment and capitalized instrument sets in cases
  • Implant growth attributed to customer increase in inventory levels
  • Surgical challenged by sluggish U.S. hospital spending, complicated by severe weather